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L E T T E R T O TH E E D I T O R
Experience and results with a telehealth treatment program
in patients with cognitive disorders during the COVID-19
pandemic
The COVID-19 pandemic has led to the adoption of social quarantine
measures in numerous countries.1 In this context, both COVID-19
and quarantine can have a substantial impact in the mental health of
affected populations.2 Health care services have had to adapt them-
selves to this new reality.
Age is the main risk factor for the development of mild cognitive
impairment (MCI) and dementia. Older adults are especially vulnerable
to severe symptoms of COVID-19 disease, which underlines the
importance of optimizing telehealth options for this population. Cur-
rently, the evidence in favor of the use of telehealth for people with
cognitive impairment (CI) is encouraging but scarce.3,4 Moreover, the
impact of social distancing and quarantine measures on activities of
daily living (ADLs) and behavioral and psychological symptoms (BPS)
of individuals with cognitive disorders is uncertain, but they are
expected to be a particularly vulnerable population. Therefore, there
is a need for developing effective strategies to reduce the risk of ADL
decline and the onset or worsening of BPS in this population.5
The aim of this letter is to present our experience and results with
a telehealth treatment program (TTP) in patients with CI during the
COVID-19 pandemic.
Prior to the start of the social distancing and quarantine mea-
sures, we had different group treatment programs (GTPs) for people
diagnosed with MCI or dementia. They consisted of group sessions of
cognitive stimulation (CS), music therapy (MT), occupational therapy
(OT), and speech and language therapy (SALT). Each session lasted
2 hours for the MCI group and 3 hours for the dementia group. The
GTP also included a medical appointment.
After the quarantine measures were instituted in our country on
March 2020, a new TTP was proposed to the patients. This TTP consisted
of one, two, or three 30-minute phone calls per week (depending on the
frequency of the sessions of the GTP) between the therapist and the
patient, accompanied by a caregiver. Materials with different activities for
CS, MT, OT, and SALT were sent a day in advance via email or WhatsApp.
This material was reviewed during the next day session. Additionally, every
patient had a telehealth medical consultation.
A Google-Doc questionnaire was sent by email or WhatsApp to
the patient's closest family caregiver of the 38 patients who attended
our GTP prior to the quarantine and was completed according to their
observations of the patients before and after 2 months of the new
TTP. The questionnaire consisted of the Barthel Index of Activities of
Daily Living (BIADL), the Lawton-Brody Instrumental Activities of
Daily Living (LBIADL) Scale, and Likert scale screening questions for
depression and anxiety.
Out of a total of 38 patients attending our GTP prior to the quar-
antine, 27 (71%) agreed to participate of the TTP. The other
11 patients had no treatment program, and only 3 (27%) had a medical
consultation for the 2-month quarantine period. No patients dropped
out of the new TTP during the 2-month follow-up period.
The questionnaire was answered by 26 family caregivers out of
38 patients (68% response rate). 19 (73%—response rate 70%) of the
patients whose relatives completed the questionnaire participated in
the TTP and 7 (27%—response rate 63%) did not. There were no sta-
tistically significant changes in the BIADL, LBIADL, nor in the levels of
depression or anxiety from the baseline scores to the end of the
follow-up period between the patients who chose not to continue
with the TTP and those who did.
In our initial experience of 2 months with a TTP for patients with CI
during the COVID-19 pandemic, there was a high adherence rate among
both patients and caregivers. However, we did not find statistically signifi-
cant differences between the groups. This could be due to different rea-
sons: lack of efficacy of the new intervention, type 2 error, ADL scales with
low sensitivity to change, short time of follow-up, or observer bias.
In summary, considering the immediate need to develop treat-
ment tools that guarantee the continuity of high-quality health care
and minimize the risks in this population during the current pandemic,
we deem that the field of telehealth treatment for older adults with CI
is promising and deserves further exploration.
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